CD169
Breg
CD169
TLS
Treg
breast cancer
lymph node
macrophage
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Feb 2023
16 Feb 2023
Historique:
received:
24
01
2023
revised:
13
02
2023
accepted:
13
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The presence of CD169
Identifiants
pubmed: 36831605
pii: cancers15041262
doi: 10.3390/cancers15041262
pmc: PMC9954705
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Swedish Research Council
ID : 2020-01842
Organisme : Swedish Cancer Society
ID : 21 1392 Pj 01 H
Organisme : Malmö allmänna sjukhuset (MAS) för bekämpande av cancer foundation
ID : 2021-2022
Organisme : Gyllenstiernska Krapperups Foundation
ID : KR 2018-0069
Organisme : Regional grants from the Swedish state under the agreement between the Swedish government and the county councils the ALF-agreement
ID : 2018-Projekt 0059
Références
Hereditary Genet. 2013;2013(Suppl 2):
pubmed: 25285241
Oncologist. 2017 Nov;22(11):1316-1324
pubmed: 28701569
Pathol Int. 2018 Dec;68(12):685-693
pubmed: 30516869
Target Oncol. 2020 Aug;15(4):415-428
pubmed: 32514907
Cancer Sci. 2018 May;109(5):1723-1730
pubmed: 29520898
Sci Rep. 2015 Oct 14;5:15179
pubmed: 26462617
Curr Oncol. 2021 May 11;28(3):1803-1822
pubmed: 34064867
Cell. 2022 May 26;185(11):1924-1942.e23
pubmed: 35525247
Breast Cancer Res Treat. 2012 Feb;131(3):939-47
pubmed: 22094937
Front Immunol. 2020 Aug 04;11:1731
pubmed: 32849616
Cancer Sci. 2016 Jun;107(6):846-52
pubmed: 26991548
Cancer Res. 2009 Mar 1;69(5):2000-9
pubmed: 19244125
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Immunotherapy. 2013 Oct;5(10):1075-87
pubmed: 24088077
Exp Mol Med. 2018 Dec 13;50(12):1-11
pubmed: 30546008
J Clin Pathol. 2016 May;69(5):422-30
pubmed: 26475777
Eur J Immunol. 2022 Oct;52(10):1581-1594
pubmed: 35907260
Cancer Immunol Res. 2015 Dec;3(12):1356-63
pubmed: 26297710
Signal Transduct Target Ther. 2021 Feb 20;6(1):72
pubmed: 33608497
J Innate Immun. 2012;4(5-6):424-36
pubmed: 22488251
Front Immunol. 2021 Mar 08;12:620510
pubmed: 33763066
Cancer Cell Int. 2021 Oct 15;21(1):536
pubmed: 34654433
Immunity. 2002 Sep;17(3):239-50
pubmed: 12354378
Genome Med. 2015 Feb 02;7(1):20
pubmed: 25722745
Front Immunol. 2017 Jun 30;8:767
pubmed: 28713385
Cell Death Dis. 2016 Nov 3;7(11):e2446
pubmed: 27809306
J Virol. 2015 May;89(9):4748-59
pubmed: 25673724
JCO Precis Oncol. 2018 Mar 09;2:
pubmed: 32913985
Immunity. 2019 Jun 18;50(6):1453-1466.e4
pubmed: 31053503
Breast Cancer. 2019 Mar;26(2):180-189
pubmed: 30244409
Breast Cancer Res. 2021 Feb 18;23(1):27
pubmed: 33602289
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6
pubmed: 22308361
Mol Oncol. 2014 Feb;8(1):119-28
pubmed: 24287398
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4215-20
pubmed: 24591636
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
Oncoimmunology. 2020 Nov 22;9(1):1848067
pubmed: 33299660
PLoS Pathog. 2013;9(4):e1003291
pubmed: 23593001
Immunity. 2019 Jun 18;50(6):1467-1481.e6
pubmed: 31201093
Eur J Immunol. 2020 Nov;50(11):1757-1769
pubmed: 32529638
Immunol Rev. 2017 Mar;276(1):178-191
pubmed: 28258691
Trends Immunol. 2012 Feb;33(2):66-70
pubmed: 22192781
Front Immunol. 2019 Feb 28;10:347
pubmed: 30891035
Oncoimmunology. 2016 Apr 29;5(7):e1177690
pubmed: 27622027
Immunity. 2015 Sep 15;43(3):579-90
pubmed: 26341400
BMC Cancer. 2015 Mar 06;15:101
pubmed: 25884667
Biomed Rep. 2021 Feb;14(2):26
pubmed: 33408860
Front Immunol. 2016 Oct 03;7:407
pubmed: 27752258
Cancer Lett. 2016 Jan 1;370(1):85-90
pubmed: 26477683
Front Immunol. 2021 Jul 28;12:697840
pubmed: 34394090
Hum Immunol. 2016 Feb;77(2):201-13
pubmed: 26686412
J Pathol. 2016 Jun;239(2):231-41
pubmed: 27174787